Publication | Open Access
Role of catecholamine degradative enzymes and the adrenergic innervation in determining the cerebrovascular response to infused norepinephrine.
10
Citations
15
References
1979
Year
Cerebral Vascular RegulationNeurovascular DiseaseIntracarotid 133XenonMolecular PharmacologyBlood FlowAdrenal GlandCatecholamine Degradative EnzymesIntracranial PressureNeurologyNeurochemistryHealth SciencesNeurotransmitter ReceptorsNeuropharmacologyVascular BiologyNervous SystemCerebral Blood FlowPharmacologyReperfusion InjuryInfused NorepinephrineAdrenergic InnervationNeurophysiologyPhysiologyNeuroscienceCentral Nervous SystemIntra-arterial InfusionMedicineBlood-borne Ne
Cerebral blood flow responses to intra-arterial infusion of norepinephrine (NE) at 0.55 microgram/kg/min and 1.1 microgram/kg/min were studied in 3 groups of baboons. The flow was measured by the intracarotid 133xenon clearance technique using a computer program to calculate flow (height over area--H/A) flow (initial slope--is) and cerebral metabolic utilization of oxygen (CMRO2). The normal response to NE was to increase flow without significant changes in CMRO2. Blockade of catechol-o-methyl transferase (COMT) produced vasoconstrictor responses to these same NE doses. Monoamine oxidase blockade abolished the normal vasodilation. Denervation of the cerebral circulation with intracisternal 6-hydroxydopamine produced vasoconstrictor responses with flow (H/A) but not with flow (is). It is concluded that the extra-neuronal COMT enzyme is important in limiting the access of blood-borne NE to cerebrovascular constrictor receptors.
| Year | Citations | |
|---|---|---|
Page 1
Page 1